sodium hydroxide has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Du, S; Gao, L; Han, J; Li, J; Niu, Z; Shi, Y; Tian, H; Wei, L; Yang, P | 1 |
1 other study(ies) available for sodium hydroxide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.
Topics: Actins; Animals; Blotting, Western; Burns, Chemical; Chromones; Corneal Injuries; Disease Models, Animal; DNA Methylation; Eye Burns; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Immunosuppressive Agents; Male; Mice; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Sirolimus; Sodium Hydroxide; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Vascular Endothelial Growth Factor A | 2021 |